US equities |
MU $877.55 ▲+2.46% NVDA $210.96 ▼-0.59% SPCX $147.49 ▲+1.89% AAPL $347.73 ▼-0.14% TSLA $372.22 ▼-0.63% SNDK $1,238.03 ▼-1.82% META $642.62 ▼-0.96% AMD $516.79 ▲+1.74%
FinancialContent

Latest News about NASDAQ:MIRA

Recent news which mentions NASDAQ:MIRA

MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing On Early Clinical Efficacy Demonstration For Neuropathic Pain In 2025
Tickers MIRA
Tags NASDAQ:MIRA
From News Direct
MIRA Stock Earnings: Mira Pharmaceuticals Misses EPS for Q2 2024
Tickers MIRA
Tags NASDAQ:MIRA MIRA Market News
From InvestorPlace
MIRA Pharmaceuticals (NASDAQ: MIRA) Reports Promising Pre-Clinical Trial Results For Mental Health Treatment, To Submit Investigational New Drug Application By End Of Year
Tickers MIRA
Tags NASDAQ:MIRA
From News Direct
MIRA Stock Earnings: Mira Pharmaceuticals Misses EPS for Q1 2024
Tickers MIRA
Tags MIRA NASDAQ:MIRA Earnings Reports
From InvestorPlace
MIRA Stock Earnings: Mira Pharmaceuticals Beats EPS for Q4 2023
Tickers MIRA
Tags Market News Earnings Reports NASDAQ:MIRA
From InvestorPlace
MIRA Pharmaceuticals debuts on the Nasdaq with plans to revolutionize medicinal CBD and THC
Tags NASDAQ:MIRA
From News Direct